Salivary Glands in Mikulicz’s Disease



Mikulicz’s disease (MD) was considered to be a subtype of Sjögren’s syndrome (SS), based on histopathological similarities. However, recent studies have indicated that patients with MD show high serum IgG4 concentrations and suggested that MD is an “IgG4-related disease” and distinguishable from SS. We examined the clinical and serological features of MD and SS in detail to determine the ways in which the two conditions can be differentiated. MD can be diagnosed quickly and simply using diagnostic criteria such as serum IgG4 values and the presence of IgG4+ cells in the salivary glands, in conjunction with salivary gland imaging, sonography, and CT scans. Glucocorticoid therapy of MD reduces IgG and IgG4 levels and improves salivary function. A negative correlation between disease duration and increasing rate of salivary flow was observed in MD.


Salivary Gland Submandibular Gland Sclerosing Cholangitis Lymphocytic Infiltration Glucocorticoid Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Morgan WS, Castleman B. A clinicopathologic study of Mikulicz’s disease. Am J Pathol. 1953;29:471–503.PubMedGoogle Scholar
  2. 2.
    Yamamoto M et al. Clinical and pathological differences between Mikulicz’s disease and Sjögren’s syndrome. Rheumatology. 2005;44:227–34.PubMedCrossRefGoogle Scholar
  3. 3.
    Hamano H et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl Med. 2001;344:732–8.CrossRefGoogle Scholar
  4. 4.
    Uchiyama-Tanaka Y et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis. 2004;43:18–25.CrossRefGoogle Scholar
  5. 5.
    Kamisawa T et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Nakazawa T et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.PubMedCrossRefGoogle Scholar
  7. 7.
    Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2011;22:1–14.PubMedCrossRefGoogle Scholar
  8. 8.
    Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol. 2012;22:21–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Yamamoto M, Takahashi H, Naishiro Y, et al. Mikulicz’s disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi. 2008;31:1–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Fujibayashi T, Sugai S, Miyasaka N, et al. Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.CrossRefGoogle Scholar
  11. 11.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol. 1968;21(5):656–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Shimizu M, Moriyama M, Okamura K, et al. Sonographic diagnosis for Mikulicz disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:105–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Shimizu M, Okamura K, Yoshiura K, et al. Sonographic diagnostic criteria for screening Sjogren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:85–93.PubMedCrossRefGoogle Scholar
  15. 15.
    Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol. 2012;67(4):297–305.PubMedCrossRefGoogle Scholar
  16. 16.
    Nakashima H, Miyake K, Moriyama M, et al. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol. 2010;73:385–91.PubMedCrossRefGoogle Scholar
  17. 17.
    Miyake K, Moriyama M, Aizawa K, et al. Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz disease associated with lymphadenopathy and pleural effusion. Mod Rhuematol. 2008;18:86–90.CrossRefGoogle Scholar
  18. 18.
    Tanaka A, Moriyama M, Nakashima H, et al. Th2 and regulatory immune reactions contributes to IgG4 production and the initiation of Mikulicz’s disease. Arthritis Rheum. 2011;64:254–63.CrossRefGoogle Scholar
  19. 19.
    Ray K. Connective tissue disease: Immune responses in Mikulicz disease differ from those in SS. Nat Rev Rheumatol. 2011;7:621.PubMedCrossRefGoogle Scholar
  20. 20.
    Maehara T, Moriyama M, Nakashima H, et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz’s disease. Ann Rheum Dis. 2012;71:2011–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Yamamoto M, Harada S, Ohara M, et al. Beneficial effects of steroid therapy for Mikulicz’s disease. Rheumatology (Oxford). 2005;44:1322–3.CrossRefGoogle Scholar
  22. 22.
    Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical SciencesKyushu UniversityFukuokaJapan

Personalised recommendations